| Europe In Vitro Diagnostics Investment Opportunities, | | | | Reagents, Microbiology Test Reagents, Infectious |
| Analysis and Forecasts to 2015 | | | | Immunology Test Reagents, Genetic Test Reagents, |
| Summary | | | | Self Testing, and Instruments. * Market shares of all |
| This report is an essential source for in-depth | | | | the key competitors including F. Hoffmann-La Roche |
| information and data relating to Europe In vitro | | | | Ltd., Abbott Laboratories, Beckman Coulter, Inc., and |
| diagnostics market. It also offers detailed and | | | | Siemens Medical Solutions, amongst others. * Key |
| comprehensive coverage of market revenue, | | | | pipeline products that are set to shape the market, |
| distribution and company share information; and the | | | | broken down by sector. * Information on the top |
| latest news, financial deals and pipeline products | | | | medical equipment companies in the sector in the |
| information of each of the key sub-segments of the in | | | | country covering business description, strategic |
| vitro diagnostics market in Europe | | | | analysis. * Healthcare structure, regulatory environment, |
| Scope | | | | approval process, pricing trends and reimbursement. * |
| * The report provides information on the European in | | | | Product and brand updates, strategy changes, R&D |
| vitro diagnostics market, broken down into detailed | | | | projects, corporate expansions and contractions and |
| categories and segments including In Vitro Diagnostics | | | | regulatory changes. * Key mergers and acquisitions, |
| Devices, Clinical Chemistry Test Reagents, | | | | partnerships, private equity investments and IPOs. * |
| Immunochemistry Test Reagents, Blood Test | | | | Customer, hospitals and physicians data. |